
Sign up to save your podcasts
Or
Dave Dillon welcomes guest Jon Forster, former executive for Medical Risk Managers for a discussion about current Market conditions of the stop loss industry. We’ll cover current stop loss products in the market, the pipeline of cell and gene therapy, and new underwriting uses of AI. Jon has 20 years’ experience in actuarial leadership positions and recently moved to work full time with the Society of Actuaries to accelerate professional development offerings.
4.6
3131 ratings
Dave Dillon welcomes guest Jon Forster, former executive for Medical Risk Managers for a discussion about current Market conditions of the stop loss industry. We’ll cover current stop loss products in the market, the pipeline of cell and gene therapy, and new underwriting uses of AI. Jon has 20 years’ experience in actuarial leadership positions and recently moved to work full time with the Society of Actuaries to accelerate professional development offerings.
1,647 Listeners
3,159 Listeners
4,337 Listeners
30,878 Listeners
26,370 Listeners
1,775 Listeners
111,397 Listeners
56,012 Listeners
9,555 Listeners
15 Listeners
5,919 Listeners
12 Listeners
2 Listeners
9,048 Listeners
14,839 Listeners